HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.

AbstractPURPOSE:
To evaluate the prognosis value of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PD-ECGF) in alpha-fetoprotein (AFP)-negative hepatocellular carcinoma (HCC) patients after curative resection.
METHODS:
Tumor tissue microarrays (TMAs) were used to detect the expressions of VEGF and PD-ECGF in consecutive 162 AFP-negative HCC patients undergoing curative resection between 1997 and 2000 in our institute. Clinicopathologic data for these patients were evaluated. The prognostic significance was assessed using Kaplan-Meier survival estimates and log-rank tests. Multivariate study with Cox's proportional hazard model was used to evaluate the prognosis-related aspects.
RESULTS:
The positive rates of VEGF and PD-ECGF in tumor tissues were 59.9% (97/162) and 62.3% (101/162), respectively. Univariate analysis showed that VEGF and PD-ECGF were prognostic factors for relapse-free survival (P = 0.034 and P = 0.033, respectively). Multivariate analyses demonstrated that the co-index (VEGF/PD-ECGF) was an independent prognostic factor for overall survival and relapse-free survival (P = 0.002 and P = 0.000, respectively).
CONCLUSION:
The co-index of VEGF and PD-ECGF is a promising independent predictor for recurrence and survival of AFP-negative HCC patients after curative resection.
AuthorsJie Hu, Yang Xu, Zao-Zhuo Shen, Zheng Wang, Qing Lu, Guo-Huan Yang, Zheng-Bin Ding, Jia Fan, Jian Zhou
JournalJournal of cancer research and clinical oncology (J Cancer Res Clin Oncol) Vol. 135 Issue 10 Pg. 1359-67 (Oct 2009) ISSN: 1432-1335 [Electronic] Germany
PMID19350273 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • alpha-Fetoproteins
  • Thymidine Phosphorylase
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (metabolism)
  • Blotting, Western
  • Carcinoma, Hepatocellular (metabolism, secondary, surgery)
  • Case-Control Studies
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Liver Neoplasms (metabolism, pathology, surgery)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (metabolism, pathology, surgery)
  • Neoplasm Staging
  • Prognosis
  • Survival Rate
  • Thymidine Phosphorylase (metabolism)
  • Tissue Array Analysis
  • Vascular Endothelial Growth Factor A (metabolism)
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: